双联抗血小板治疗非心源性缺血性脑卒中的疗效及安全性研究现状

[1] PON1基因rs854572单核苷酸多态性与氯吡格雷抵抗的相关性研究 [J]. 解放军医学杂志, 2012, 37 (10) : 982 - 986

[2] 抗血小板药物作用机制及应用 [J]. 中国实用医刊, 2012, (06) : 104 - 106

[3] 急性缺血性卒中/短暂性脑缺血发作的早期抗血小板治疗研究进展 [J]. 中国新药杂志, 2011, (11) : 968 - 972

[4] 阿司匹林和氯吡格雷所致胃肠道损伤的防治策略 [J]. 中国实用内科杂志, 2011, 31 (05) : 336 - 337

[5] 轻度脑卒中急性期睡眠障碍影响因素和失眠者药物干预的疗效分析 [J]. 解放军医学杂志, 2010, (02) : 212 - 215

[6] CLAIR研究对急性缺血性卒中治疗的启示 [J]. 国际脑血管病杂志, 2010, (01) : 1 - 3

[7] Platelet‐Oriented Inhibition in New TIA and Minor Ischemic Stroke （ POINT ） Trial: Rationale and design[J] . S. Claiborne Johnston,J. Donald Easton,Mary Farrant,William Barsan,Holly Battenhouse,Robin Conwit,Catherine Dillon,Jordan Elm,Anne Lindblad,Lewis Morgenstern,Sharon N. Poisson,Yuko Palesch.Int J Stroke . 2013 (6)

[8] Effect of clopidogrel plus ASA vs. ASA early after TIA and ischaemic stroke: a substudy of the CHARISMA trial[J] . Graeme J.Hankey,S. ClaiborneJohnston,J. DonaldEaston,WernerHacke,Jean‐LouisMas,DanielleBrennan,Koon HouMak,Deepak L.Bhatt,Keith A. A.Fox,Eric J.Topol.International Journal of Stroke . 2011 (1)

[9] Clopidogrel plus aspirin versus aspirin alone for reducing embolisation in patients with acute symptomatic cerebral or carotid artery stenosis （CLAIR study）: a randomised, open-label, blinded-endpoint trial[J] . Ka Sing Lawrence Wong,Christopher Chen,Jianhui Fu,Hui Meng Chang,Nijasri C Suwanwela,Yining N Huang,Zhao Han,Kay Sin Tan,Disya Ratanakorn,Pavithra Chollate,Yudong Zhao,Angeline Koh,Qing Hao,Hugh S Markus.Lancet Neurology . 2010 (5)

[10] Rationale and design of a randomized, double-blind trial comparing the effects of a 3-month clopidogrel-aspirin regimen versus aspirin alone for the treatment of high-risk patients with acute nondisabling cerebrovascular event[J] . Yongjun Wang,S. Claiborne Johnston.American Heart Journal . 2010 (3)

[1] PON1基因rs854572单核苷酸多态性与氯吡格雷抵抗的相关性研究 [J]. 解放军医学杂志, 2012, 37 (10) : 982 - 986

[2] 抗血小板药物作用机制及应用 [J]. 中国实用医刊, 2012, (06) : 104 - 106

[3] 急性缺血性卒中/短暂性脑缺血发作的早期抗血小板治疗研究进展 [J]. 中国新药杂志, 2011, (11) : 968 - 972

[4] 阿司匹林和氯吡格雷所致胃肠道损伤的防治策略 [J]. 中国实用内科杂志, 2011, 31 (05) : 336 - 337

[5] 轻度脑卒中急性期睡眠障碍影响因素和失眠者药物干预的疗效分析 [J]. 解放军医学杂志, 2010, (02) : 212 - 215

[6] CLAIR研究对急性缺血性卒中治疗的启示 [J]. 国际脑血管病杂志, 2010, (01) : 1 - 3

[7] Platelet‐Oriented Inhibition in New TIA and Minor Ischemic Stroke （ POINT ） Trial: Rationale and design[J] . S. Claiborne Johnston,J. Donald Easton,Mary Farrant,William Barsan,Holly Battenhouse,Robin Conwit,Catherine Dillon,Jordan Elm,Anne Lindblad,Lewis Morgenstern,Sharon N. Poisson,Yuko Palesch.Int J Stroke . 2013 (6)

[8] Effect of clopidogrel plus ASA vs. ASA early after TIA and ischaemic stroke: a substudy of the CHARISMA trial[J] . Graeme J.Hankey,S. ClaiborneJohnston,J. DonaldEaston,WernerHacke,Jean‐LouisMas,DanielleBrennan,Koon HouMak,Deepak L.Bhatt,Keith A. A.Fox,Eric J.Topol.International Journal of Stroke . 2011 (1)

[9] Clopidogrel plus aspirin versus aspirin alone for reducing embolisation in patients with acute symptomatic cerebral or carotid artery stenosis （CLAIR study）: a randomised, open-label, blinded-endpoint trial[J] . Ka Sing Lawrence Wong,Christopher Chen,Jianhui Fu,Hui Meng Chang,Nijasri C Suwanwela,Yining N Huang,Zhao Han,Kay Sin Tan,Disya Ratanakorn,Pavithra Chollate,Yudong Zhao,Angeline Koh,Qing Hao,Hugh S Markus.Lancet Neurology . 2010 (5)

[10] Rationale and design of a randomized, double-blind trial comparing the effects of a 3-month clopidogrel-aspirin regimen versus aspirin alone for the treatment of high-risk patients with acute nondisabling cerebrovascular event[J] . Yongjun Wang,S. Claiborne Johnston.American Heart Journal . 2010 (3)